biotechs oversold -quality rebound

  1. 214 Posts.
    Better quality biotechs have suffered with the rest.
    Rebounds likely for those with proven technologies, revenues in near future and strong cash positions.
    Well positioned in this category are PTD, NAL, PSD and SPL.
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.